Oncolytics Biotech (ONCY) Times Interest Earned (2019 - 2025)
Oncolytics Biotech's (ONCY) quarterly Times Interest Earned came in at -$443.0 in Q3 2025, down 96.08% year-on-year from -$11300.1 in Q3 2024, and down 133.09% on a QoQ basis from -$190.06 in Q2 2025.
Oncolytics Biotech (ONCY) Times Interest Earned (2019 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 7 years of Times Interest Earned data on file, last reported at -$443.0 in Q3 2025.
- On a quarterly basis, Times Interest Earned fell 96.08% year-over-year to -$443.0 in Q3 2025; TTM through Sep 2025 was -$267.23, a 202.31% decrease from a year earlier, with the FY2025 full-year figure at -$0.72, down 1.45% from the prior year.
- Times Interest Earned for Q3 2025 stood at -$443.0, down from -$190.06 in the prior quarter.
- Over the last five years, Times Interest Earned for ONCY reached as high as $299.34 in Q2 2021 and fell as low as -$1714.5 in Q4 2021.
- Historically, Times Interest Earned has averaged -$177.9 across 5 years, with a median of -$190.06 in 2025.
- Across the five-year window, Times Interest Earned jumped 164.03% in 2021 and slumped 268.91% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$1714.5 in 2021, then soared by 117.01% to $291.69 in 2022, then plunged by 172.89% to -$212.61 in 2023, then rose by 6.47% to -$198.85 in 2024, then tumbled by 122.78% to -$443.0 in 2025.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$443.0 in Q3 2025, -$190.06 in Q2 2025, and -$198.85 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -443.00 |
| Jun 30, 2025 | -190.06 |
| Dec 31, 2024 | -198.85 |
| Sep 30, 2024 | -225.93 |
| Jun 30, 2024 | -169.50 |
| Dec 31, 2023 | -212.61 |
| Sep 30, 2023 | 133.76 |
| Jun 30, 2023 | -99.61 |
| Mar 31, 2023 | 68.08 |
| Dec 31, 2022 | 291.69 |
| Sep 30, 2022 | -217.95 |
| Jun 30, 2022 | 234.60 |
| Mar 31, 2022 | -286.12 |
| Dec 31, 2021 | -1,714.46 |
| Sep 30, 2021 | 174.16 |
| Jun 30, 2021 | 299.34 |
| Mar 31, 2021 | -467.90 |
| Dec 31, 2020 | 2,043.43 |
| Sep 30, 2020 | -378.35 |
| Jun 30, 2020 | -467.52 |